SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ciphergen Biosystems(CIPH):
An SI Board Since September 2000
Posts SubjectMarks Bans
510 15 0
Emcee:  mact Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
135This would seem to validate CIPH's contention that SELDI beats SDS-PAGE. Untuck-6/19/2003
134Medscape looked at the AACR abstracts before the meeting was canceled. Now thattuck-6/18/2003
133Tom, My guess is that CIPH could outperform biotech for the next month, since Ctuck-6/6/2003
132I just looked at the CIPH chart (I own a very small amount in the shoe box) - evtom pope-6/4/2003
131I wonder if this deal was held back by the recently settled litigation. If so, tuck-6/4/2003
130FREMONT, Calif., June 3 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (Natuck-6/3/2003
129>>FREMONT, Calif., June 2 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, tuck-6/2/2003
128Ciphergen Announces Settlement of Lawsuit Thursday May 29, 8:59 pm ET Settlemesmh-5/29/2003
127Someone outside Ciphergen finally uses the technology to speed optimization of ptuck-5/29/2003
126The FDA has gone public with its thinking on in vitro diagnostics with multiplextuck-5/28/2003
125Finally, a drug discovery team from Abbott provides their take on why they like tuck-5/27/2003
124The Hopkins team mentioned in the previous post receives funding from CIPH in retuck-5/27/2003
123I don't remember seeing SELDI used for pancreatic cancer detection before: tuck-5/27/2003
122However, this abstract from the same team concerning prostate cancer <b>dotuck-5/27/2003
121Found the abstract, but still no specific mention of the type of MS used, or whetuck-5/27/2003
120>>Biometrics 2003 Mar;59(1):143-51 Data reduction using a discrete waveltuck-5/27/2003
119Parking this link; will follow up by finding the AACR abstract. Wonder what kintuck-5/19/2003
118tuck, Once you have the reagents, immunoassays are fast, reliable and fairly chBiomaven-5/14/2003
117Well, the 10-K claims they have patents on various things, including software. tuck-5/14/2003
116tuck, As I understand it (and I could well be wrong) CIPH's IP is in the maBiomaven-5/14/2003
115Hi, Peter, Advion is a competitor in pretty indirect fashion. I had a gander atuck-5/14/2003
114tuck, Sounds to me like Advion is a competitor to CIPH. advion.com PeterBiomaven-5/14/2003
113Do not know if CIPH has a piece of this. The '02 test that found the markertuck-5/14/2003
112cool! thanks. (eom)scaram(o)uche-5/7/2003
111>>Ann Surg 2003 May;237(5):660-5 Characterization of renal allograft rejtuck-5/6/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News